Clish, Clary B
- Beth Israel Deaconess Medical Center · Internal Medicine (investigator's affiliation)
- Harvard T.H. Chan School of Public Health (no department on record)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
FY2023 NIH rank #4,038
- R01 Holder
- Early Career
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2021 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
NIH Funding · FY2023
Linked Award Amount
$1.9M
Full award amounts, FY2023
Award Records
2
Records listing this PI
Award-Linked Rank
#4,038
By linked amount among FY2023 PIs
Earliest Year Loaded
2021
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2023 award records by amount
NIH award records listing Clish, Clary B as a PI. Multi-PI records show the full award amount for context.
- 5U2CDK129670-03U2CContact PIDietary Biomarkers Development Center at Harvard University$1.3Maward amount
- 5R01DK081572-13R01Contact PIMetabolomic predictors of insulin resistance and diabetesBeth Israel Deaconess Medical Center · Internal Medicine (investigator's affiliation)$621.3Kaward amount
Award organizations
Organizations that administered FY2023 awards listing Clish, Clary B as a PI.
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2021First NIH AwardHarvard T.H. Chan School of Public Health
- 2021$500K Cumulative Funding
- 2021$1M Cumulative Funding
- 2021$2M Cumulative Funding
- 2021Entered Top 50% NationallyRanked #2969
- 2021Entered Top 25% NationallyRanked #2969
- 2022Multi-Institutional ResearchAwards at 2 institutions
- 2022R01 Grant Holder
- 2023$5M Cumulative Funding